Refine by
Covid Emergency Articles & Analysis
48 news found
Initiated 2020 by ExcellGene’s research and funded since April 2022 deep insights into the immunogenicity of the various COVID virus variants have emerged. The collaboration showed that ultrapure antigen preparations made by scientists and engineers at ExcellGene in Monthey with the help of Chinese Hamster Ovary (CHO) cells in bioreactors are highly ...
Therefore, these vectors represent a promising strategy e.g., against emerging diseases such as Covid-19. This is emphasized by the fact that the WHO lists several vector derived “vaccine candidates” in advanced clinical development against Covid-19, some of which are already on the market.[1] Types of viral vectors in ...
ByNuvonis
(Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced Mayo Clinic is initiating an investigator-initiated study to assess the efficacy of gammaCore Sapphire non-invasive vagus nerve stimulation (nVNS) in patients with post-COVID syndrome. Post-COVID syndrome, also known as Long COVID, is a collection of symptoms that ...
The Phase 3 trial, which began in the US earlier this year, is evaluating the ability of UB-612 to boost COVID-19 immunity against the original strain and multiple variants of concern including Omicron - in people aged 16 years or older, who have been previously immunized with an authorized COVID-19 vaccine. ...
ByVaxxinit
The Phase 2 study is designed to assess whether the addition of SCIB1 to pembrolizumab (Keytruda®) will result in an improvement in the tumour response rate, progression-free survival and overall survival in patients with advanced melanoma, who are also eligible for treatment with pembrolizumab. As a result of the COVID-19 pandemic, screening and recruitment into the study ...
ByScancell
The study, “Assessment of a cellular host response test to risk-stratify suspected COVID-19 patients in the Emergency Department setting,” demonstrated that the IntelliSep test has the potential to rapidly risk-stratify patients independent of pathogen, an important finding as risk stratification may improve resource allocation in hospitals. ...
"Testing is going to be a routine practice for many as we emerge from the COVID-19 pandemic and look to prepare for possible new variants to come, while also addressing current variants. ...
We successfully repurposed our novel antibody, Alzumab-L (itolizumab) to serve the needs of Covid patients in India. And we recently partnered with Boston based Adagio Therapeutics to manufacture and commercialize a promising antibody therapy for Covid-19 in India and select emerging markets. ...
ByBiocon
INOVIO (NASDAQ:INO), a biotechnology company focused on bringing to market precisely designed DNA medicines to help protect people from infectious diseases and treat cancer and HPV-associated diseases, today announced the company is rapidly moving to evaluate its COVID-19 DNA vaccine candidates INO-4800 and INO-4802 against the emerging B.1.1.529 (Omicron) ...
ALung has been conducting the VENT-AVOID pivotal clinical trial for the treatment of Chronic Obstructive Pulmonary Disease (COPD) exacerbations and providing the Hemolung for the treatment of COVID-19 patients under an Emergency Use Authorization (EUA) granted by the FDA. ...
The free eBook has been created as a tool to help organisations identify common areas of concern within any diagnostics development programme and help create a refined development roadmap, ensuring complete end-to-end project visibility and a streamlined route to market. The Covid 19 pandemic has had a noticeable impact on the MedTech landscape, specifically within the field of ...
This year’s annual assessment report provided much needed global awareness for technologies that could have an immediate impact on COVID-19 and other general health outcomes. The portable MediPines AGM100 was selected for its ability to “instantly detect changes in pulmonary gas exchange in disease states such as COPD, pneumonia, influenza, and ARDS caused by ...
“Telehealth, particularly during the COVID-19 pandemic, has emerged as a preferred option for healthcare providers. ...
(“Stemedica”), a San Diego-based biotech company specializing in the manufacture of clinical grade stem cells, announces enrollment of patients for its study entitled “A Phase II, Double-blind, Placebo-controlled Study to Assess the Safety, Tolerability, and Preliminary Efficacy of Intravenous Allogeneic Mesenchymal Stem Cells in Patients With Moderate to Severe ARDS Due to ...
Given what we know about the 1918 pandemic, combined with current knowledge derived from the COVID-19 crisis, it is obvious that vaccine development needs to strategize for broad and enduring efficacy. ...
The 1,000 m2 production site is now operational and will give Fab'entech the capacity to manufacture all of its innovations (biodefense and anti-COVID-19 programme: FabenCOV) in France. Close-up of this new site, a key asset in the development of the biotech's activities. ...
Clinical diagnostic and hospital laboratories across the United States have ramped up PCR testing over the last year in response to the global COVID-19 pandemic. These laboratories are now seeking solutions to continue to screen for COVID-19 after emergency use authorizations (EUAs) for SARS-CoV-2 assays expire. "The COVID-19 ...
This advanced respiratory monitoring system was designed to rapidly detect respiratory impairment caused by conditions such as COVID-19, chronic obstructive pulmonary disease (COPD), pneumonia, ARDS, pulmonary edema, and pulmonary embolism. The device is FDA cleared and approved for Health Canada COVID-19 Emergency Use. It provides a ...
Nebraska Today recently sat down for a conversation with Benson, professor of food science and director of the center, and Hutkins, Khem Shahani Distinguished Professor of Food Science, to discuss how our food choices affect our health, what sets Nebraska apart in the research of the gut microbiome, and what research will emerge following the COVID-19 pandemic. ...
Organized by FederUnacoma, the Italian association of agricultural machinery manufacturers, the Bologna event - the first event for the agromechanical sector that takes place "physically" after the restrictions imposed by the Covid 19 emergency - will be the international showcase of the latest generation technologies applied to agriculture, and it will offer ...